R1’s proprietary technology, including automations, workflows and algorithms, built to reduce costs and drive revenue yield for the healthcare industry, will use Microsoft Azure OpenAI Service and other Azure AI services to rapidly introduce new product capabilities and drive greater productivity, improved customer and patient experiences, and faster time to value.
R1 recently delivered its first large language model (LLM) application that increases the productivity of physician coding quality assurance, integrating tools from
“R1 offers a unique combination of software and services, and we are leading the next wave of advanced technology for the healthcare revenue cycle – first with automation, then machine learning, and now with large language models and AI,” said
R1’s technology roadmap features an array of initiatives leveraging LLMs on applications across the revenue cycle, from call centers to payer follow-up to scheduling and automation of accounts receivable activities.
“With the significant financial and staffing challenges facing healthcare providers today, Microsoft Azure AI plays a critical role in helping the industry achieve greater efficiencies, improved financial performance and increase quality of care,” said
R1’s customer base, including 95 of the largest 100 health systems in the
Forward-Looking Statements
This press release contains “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events and relationships, plans, future growth, and future performance. These statements are often identified by the use of words such as “anticipate,” “believe,” “contemplate,” “designed,” “estimate,” “expect,” “forecast,” “goal,” “intend,” “may,” “outlook,” “plan,” “predict,” “project,” “see,” “seek,” “target,” “would,” and similar expressions or variations or negatives of these words, although not all forward-looking statements contain these identifying words. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the R1’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, assurance, prediction or definitive statement of fact or probability. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks, and changes in circumstances, including but not limited to risk and uncertainties related to: (i) economic downturns and market conditions beyond R1’s control, including periods of inflation; (ii) the quality of global financial markets; (iii) R1’s ability to timely and successfully achieve the anticipated benefits and potential synergies of the acquisition of Cloudmed; (iv) R1’s ability to retain existing customers or acquire new customers; (v) the development of markets for R1’s revenue cycle management offering; (vi) variability in the lead time of prospective customers; (vii) competition within the market; (viii) breaches or failures of R1’s information security measures or unauthorized access to a customer’s data; (ix) delayed or unsuccessful implementation of R1’s technologies or services, or unexpected implementation costs; (x) disruptions in or damages to R1’s global business services centers and third-party operated data centers; (xi) the volatility of R1’s stock price; and (xii) R1’s substantial indebtedness. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements are included under the heading “Risk Factors” in R1’s annual report on Form 10-K for the year ended
About
R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. R1’s proven and scalable operating models seamlessly complement a healthcare organization’s infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com.
Contact:
Investor Relations:
516.743.5184
investorrelations@r1rcm.com
Media Relations:
R1PR@allisonpr.com
Source:
2023 GlobeNewswire, Inc., source